73 related articles for article (PubMed ID: 27330357)
1. Trends in health care utilization and costs attributable to hepatocellular carcinoma, 2002-2009: a population-based cohort study.
Thein HH; Qiao Y; Young SK; Zarin W; Yoshida EM; de Oliveira C; Earle CC
Curr Oncol; 2016 Jun; 23(3):e196-220. PubMed ID: 27330357
[TBL] [Abstract][Full Text] [Related]
2. Health care costs associated with hepatocellular carcinoma: a population-based study.
Thein HH; Isaranuwatchai W; Campitelli MA; Feld JJ; Yoshida E; Sherman M; Hoch JS; Peacock S; Krahn MD; Earle CC
Hepatology; 2013 Oct; 58(4):1375-84. PubMed ID: 23300063
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
4. An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data.
Bremner KE; Krahn MD; Warren JL; Hoch JS; Barrett MJ; Liu N; Barbera L; Yabroff KR
Palliat Med; 2015 Dec; 29(10):918-28. PubMed ID: 26330452
[TBL] [Abstract][Full Text] [Related]
5. Phase-specific healthcare costs of cervical cancer: estimates from a population-based study.
Liu N; Mittmann N; Coyte PC; Hancock-Howard R; Seung SJ; Earle CC
Am J Obstet Gynecol; 2016 May; 214(5):615.e1-615.e11. PubMed ID: 26627729
[TBL] [Abstract][Full Text] [Related]
6. The lifetime cost of hepatocellular carcinoma : a claims data analysis from a medical centre in Taiwan.
Lang HC; Wu JC; Yen SH; Lan CF; Wu SL
Appl Health Econ Health Policy; 2008; 6(1):55-65. PubMed ID: 18774870
[TBL] [Abstract][Full Text] [Related]
7. Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study.
Thein HH; Jembere N; Thavorn K; Chan KKW; Coyte PC; de Oliveira C; Hur C; Earle CC
BMC Cancer; 2018 Jun; 18(1):694. PubMed ID: 29945563
[TBL] [Abstract][Full Text] [Related]
8. Health care resource use associated with integrated psychological treatment.
Vasiliadis HM; Briand C; Lesage A; Reinharz D; Stip E; Nicole L; Lalonde P
J Ment Health Policy Econ; 2006 Dec; 9(4):201-7. PubMed ID: 17200597
[TBL] [Abstract][Full Text] [Related]
9. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
10. Trends and predictors of outcomes after surgery for hepatocellular carcinoma: A nationwide population-based study in Taiwan.
Chiu CC; Wang JJ; Chen YS; Chen JJ; Tsai TC; Lai CC; Sun DP; Shi HY
Eur J Surg Oncol; 2015 Sep; 41(9):1170-8. PubMed ID: 26048295
[TBL] [Abstract][Full Text] [Related]
11. Phase-specific and lifetime costs of cancer care in Ontario, Canada.
de Oliveira C; Pataky R; Bremner KE; Rangrej J; Chan KK; Cheung WY; Hoch JS; Peacock S; Krahn MD
BMC Cancer; 2016 Oct; 16(1):809. PubMed ID: 27756310
[TBL] [Abstract][Full Text] [Related]
12. Costs of cancer care in children and adolescents in Ontario, Canada.
de Oliveira C; Bremner KE; Liu N; Greenberg ML; Nathan PC; McBride ML; Krahn MD
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28500732
[TBL] [Abstract][Full Text] [Related]
13. Patient time costs associated with cancer care.
Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
[TBL] [Abstract][Full Text] [Related]
14. Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older.
Collard HR; Chen SY; Yeh WS; Li Q; Lee YC; Wang A; Raghu G
Ann Am Thorac Soc; 2015 Jul; 12(7):981-7. PubMed ID: 25923447
[TBL] [Abstract][Full Text] [Related]
15. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
16. Healthcare costs associated with prostate cancer: estimates from a population-based study.
Krahn MD; Zagorski B; Laporte A; Alibhai SM; Bremner KE; Tomlinson G; Warde P; Naglie G
BJU Int; 2010 Feb; 105(3):338-46. PubMed ID: 19594734
[TBL] [Abstract][Full Text] [Related]
17. Resource utilization and costs of managing patients with advanced melanoma: a Canadian population-based study.
Gwadry-Sridhar F; Nikan S; Hamou A; Seung SJ; Petrella T; Joshua AM; Ernst S; Mittmann N
Curr Oncol; 2017 Jun; 24(3):168-175. PubMed ID: 28680276
[TBL] [Abstract][Full Text] [Related]
18. Mortality and hospital utilization for hepatocellular carcinoma in the United States.
Kim WR; Gores GJ; Benson JT; Therneau TM; Melton LJ
Gastroenterology; 2005 Aug; 129(2):486-93. PubMed ID: 16083705
[TBL] [Abstract][Full Text] [Related]
19. Resource implications of palliative chemotherapy for ovarian cancer.
Doyle C; Stockler M; Pintilie M; Panesar P; Warde P; Sturgeon J; Oza AM
J Clin Oncol; 1997 Mar; 15(3):1000-7. PubMed ID: 9060539
[TBL] [Abstract][Full Text] [Related]
20. Health system costs for stage-specific breast cancer: a population-based approach.
Mittmann N; Porter JM; Rangrej J; Seung SJ; Liu N; Saskin R; Cheung MC; Leighl NB; Hoch JS; Trudeau M; Evans WK; Dainty KN; DeAngelis C; Earle CC
Curr Oncol; 2014 Dec; 21(6):281-93. PubMed ID: 25489255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]